Do Vitamin D and Omega-3 Preserve Muscle After 70?

Healthy older adults got no extra muscle benefit from the stack

If you are over 70, mobile, active, and already free of vitamin D deficiency, a daily stack of vitamin D3, omega-3, and simple home exercise may add little to muscle preservation. In the three-year DO-HEALTH randomized trial, none of those interventions—alone or combined—significantly improved appendicular lean mass index, a DXA-based measure of limb lean mass, in the study's muscle-mass subgroup.

That result does not mean vitamin D, omega-3, or exercise are useless. It means the answer depends heavily on who takes them and what they are trying to correct. DO-HEALTH studied older adults selected for relatively good health, mobility, cognition, and vitamin D status. That is a very different population from people with vitamin D deficiency, inactivity, frailty, or established sarcopenia.

The trial tests a popular assumption in the healthy-aging market: add several plausible interventions and their benefits will accumulate. Here, the pile-up produced mostly null results.

What DO-HEALTH tested

The 2025 DO-HEALTH muscle-mass analysis by Eggimann et al. drew on a larger trial of 2,157 community-dwelling adults aged 70 or older in five European countries. Participants received one of eight factorial combinations of daily vitamin D3 (2,000 IU), omega-3 fatty acids (1 g, providing 330 mg EPA and 660 mg DHA), and a simple home exercise program, or their corresponding comparators, for three years.

The eligibility criteria matter. Participants had adequate unaided mobility, no severe gait impairment, an MMSE score of at least 24, no major cardiovascular event or cancer in the previous five years, and confirmed absence of vitamin D deficiency. The program also did not recruit a population defined by sarcopenia or functional decline.

The exercise intervention was modest: five fixed movements—sit-to-stand, single-leg stance, elastic-band pull-back, external shoulder rotation, and stair stepping—performed as three sets of 10 repetitions, three times weekly. It was practical, but it did not progressively increase resistance or training load over the three years.

No significant change in lean mass

Among 1,495 participants with DXA measurements, vitamin D3, omega-3, and the home exercise program produced no statistically significant improvement in appendicular lean mass index over three years. The analysis was powered to detect a 0.05 kg/m² difference in appendicular lean mass index, yet no intervention arm reached that threshold. The null finding also held in prespecified subgroups with low baseline lean mass, defined as below 5.5 kg/m² in women and below 7.0 kg/m² in men.

The combinations did not rescue the result. No two-way or three-way interaction significantly improved lean-mass change. In practical terms, the triple combination did not outperform the single interventions or placebo on this endpoint.

One result deserves separate treatment. In the incident-sarcopenia analysis, involving 1,940 participants, the omega-3-by-exercise interaction reached statistical significance (p=0.01). That is an interesting signal, not proof of synergy. It came from a secondary or exploratory outcome in an eight-group factorial design with many possible comparisons. The other combination analyses were null, and no independent trial has yet replicated this finding.

Physical activity did not rise either

A separate 2025 DO-HEALTH analysis by Hussein et al. evaluated physical activity and function across all 2,157 participants. Neither omega-3 nor the simple home exercise program significantly improved total physical activity, sedentary time, or activity intensity over three years. The interventions also did not improve gait speed, sit-to-stand performance, grip strength, or Short Physical Performance Battery score.

Vitamin D3 produced the trial's oddest result: participants assigned to 2,000 IU daily reported a statistically significant decline of 7.1 MET-hours per week in physical activity versus placebo. The study does not establish why. Behavioral compensation, physiology, and chance are all possible explanations, but none has been demonstrated. The result should not become a reason for a vitamin-D-deficient person to avoid treatment.

The authors also cite the VITAL trial, which used the same 2,000-IU vitamin D dose and found no benefit for gait speed, grip strength, sit-to-stand performance, or Short Physical Performance Battery score. Two large trials with null functional findings make a broad promise for vitamin D in already replete older adults hard to defend.

Why the exercise result is not a verdict on exercise

DO-HEALTH's home program was designed for feasibility, not progressive overload. Muscle usually needs a training stimulus that becomes harder as the body adapts. Repeating the same fixed-load routine for three years may improve familiarity and balance confidence, but it gives limited reason to expect hypertrophy in active people.

This distinction fits the wider exercise evidence. A 2023 network meta-analysis by Shen et al. found that resistance and multicomponent exercise programs outperform lighter home-based approaches for sarcopenia outcomes. A second 2023 network meta-analysis likewise reported improved handgrip strength and timed-up-and-go performance with resistance training in older adults with sarcopenia.

Those findings do not contradict DO-HEALTH so much as define its boundary. A light, non-progressive protocol in healthy, active participants is not equivalent to progressive resistance training in people who already have sarcopenia.

Deficit populations can respond

The contrast becomes sharper in trials that enroll people with a problem to treat. A 2025 multicenter randomized trial by Sun et al. found meaningful improvements in proxy measures of muscle mass, strength, and function after 12 weeks of combined nutritional supplementation and exercise in older adults with sarcopenia. A 2025 nursing-home trial also reported improvements in skeletal muscle index, muscle mass, and function after 12 weeks of Otago exercise plus resistance training in pre-frail older adults with sarcopenia.

These studies do not prove that every supplement stack works. They do show why baseline status changes the question. A person with sarcopenia, poor diet, low omega-3 status, vitamin D deficiency, or low activity has room for an intervention to help. A healthy, active, nutritionally replete person may not.

Omega-3 evidence remains mixed. A 2022 meta-analysis by Rondanelli et al. reported benefits of EPA and DHA supplementation for fat-free mass and physical performance in elderly participants. Its pooled trials may have included people with lower omega-3 status or poorer function than DO-HEALTH participants. Dose may also matter: DO-HEALTH used 1 g daily, and the available evidence cannot separate a possible dose issue from the possibility that participants simply had little deficit to correct.

Likewise, lower blood 25-hydroxyvitamin D has been associated with later sarcopenia in observational research, including a 2025 two-year follow-up study. Association does not establish that supplementation improves muscle in people whose vitamin D level is already adequate. Sarcopenia itself can reduce outdoor activity and sun exposure, which can lower vitamin D levels.

What to do with this evidence

For healthy, active adults over 70 without vitamin D deficiency, DO-HEALTH gives little reason to expect 2,000 IU of vitamin D3, 1 g of omega-3, or this particular home routine to preserve more muscle or create more activity over three years. It also gives little support for stacking all three in hopes of an additive lean-mass benefit.

For people with a documented deficiency, low activity, frailty, or sarcopenia, this trial is not the right template. Testing for a real deficit and addressing it is more defensible than treating supplements as insurance against every feature of aging. For muscle preservation, the evidence favors a progressive resistance program tailored to ability; DO-HEALTH did not test that intervention.

The useful lesson is narrower than "supplements do not work." In healthy, replete older adults, these doses and this fixed home program did not improve the muscle or activity outcomes that matter most.